Mark Robert Baker Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mark Robert Baker.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mark Robert Baker. Mark Robert Baker is a CEO in PROGENICS PHARMACEUTICALS INC ($PGNX) and an Chief Executive Officer in PROGENICS PHARMACEUTICALS INC ($PGNX) and a General Counsel in PROGENICS PHARMACEUTICALS INC ($PGNX) and a President in PROGENICS PHARMACEUTICALS INC ($PGNX).

Address: 777 OLD SAW MILL RIVER ROAD TARRYTOWN 10591 NY

Companies in which Mark Robert Baker is an Insider

PROGENICS PHARMACEUTICALS INC

Trading Symbol: PGNX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Robert Baker: Chief Executive Officer, CEO, President, General Counsel
Holdings: 161,141 shares
Current Value: $1,535,674
Latest Transaction: Mar 05 2019
$PGNX Market Capitalization: $671.09M
$PGNX Previous Close: $9.53

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Mark Robert Baker

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 05 2019PGNXPROGENICS PHARMACE ...Baker Mark RobertChief Executive Off ...Option ExerciseA4.52192,500870,100192,500
Mar 02 2018PGNXPROGENICS PHARMACE ...Baker Mark RobertChief Executive Off ...Option ExerciseA6.62201,2501,332,275201,250
Mar 07 2017PGNXPROGENICS PHARMACE ...Baker Mark RobertChief Executive Off ...Option ExerciseA11.32175,0001,981,000175,000
Mar 03 2016PGNXPROGENICS PHARMACE ...Baker Mark RobertCEOOption ExerciseA4.52175,000791,000175,000
Mar 04 2015PGNXPROGENICS PHARMACE ...Baker Mark RobertCEOOption ExerciseA6.65132,000877,800132,000
Mar 04 2014PGNXPROGENICS PHARMACE ...Baker Mark RobertCEOOption ExerciseA4.70132,000620,400132,000
Apr 08 2013PGNXPROGENICS PHARMACE ...Baker Mark RobertCEOOption ExerciseA5.03120,000603,600120,000

View all Mark Robert Baker insider transactions.